PDK1 and breast cancer: Loss of miR-375 has also been reported in gastric, liver and breast cancers, and a putative tumor suppressor role has been linked to a failure to repress the oncogenic miR-375 targets JAK2, YAP, PDK1 and RASD1 [46], [47], [48], [49].